The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium

Journal of Investigative Dermatology

Volumn 120, Issue 3, 2003, Pages 379-389

  Heilborn, Johan D ^a   Frohm Nilsson, Margareta ^a   Kratz, Gunnar ^a   Weber, Günther ^a   Sørensen, Ole ^a   Borregaard, Niels ^b   Ståhle Bäckdahl, Mona ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Rigshospitalet   (Denmark)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cationic peptide; Keratinocyte; Leg ulcer; Proliferation; Wound healing

Indexed keywords

ANTIINFECTIVE AGENT; CATHELICIDIN; KI 67 ANTIGEN; PEPTIDE;

ADULT; AGED; ANTIBODY AFFINITY; ANTIGEN BINDING; ANTIMICROBIAL ACTIVITY; ARTICLE; CELL MIGRATION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; EPITHELIZATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; INFLAMMATORY INFILTRATE; MALE; ORGAN CULTURE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SECRETION; SKIN EPITHELIUM; SKIN INJURY; SKIN ULCER; WOUND CLOSURE; WOUND HEALING;

EID: 0037335205     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2003.12069.x     Document Type: Article

References (44)

1. Agerberth B, Gunne H, Odeberg J, Kogner P, Boman HG, Gudmundsson GH: FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc Natl Acad Sci USA 92:195-199, 1995
2. Agerberth B, Charo J, Werr J, et al: The human anti-microbial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood 96:3086-3093, 2000
3. Bals R, Wang X, Zasloff M, Wilson JM: The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad anti-microbial activity at the airway surface. Proc Natl Acad Sci USA 95:9541-9546, 1998
4. Bennett NT, Schultz GS: Growth factors and wound healing: Part II. Role in normal and chronic wound healing. Am J Surg 166:74-81, 1993
5. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976
6. Bucalo B, Eaglestein WH, Falanga V: Inhibition of cell proliferation by chronic wound fluid. Wound Repair Regen 1:181-186, 1993
7. Cowland JB, Johnsen AH, Borregaard N: hCAP-18, a cathelin/pro-bactenecin-like protein of human neutrophil specific granules. FEBS Lett 368:173-176, 1995
8. De Y, Chen Q, Schmidt AP, et al: LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells [In Process Citation]. J Exp Med 192:1069-1074, 2000
9. Dorschner RA, Pestonjamasp VK, Tamakuwala S, et al: Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol 117:91-97, 2001
10. Echtermeyer F, Streit M, Wilcox-Adelman S, Saoncella S, Denhez F, Detmar M, Goetinck P: Delayed wound repair and impaired angiogenesis in mice lacking syndecan- 4. J Clin Invest 107:R9-R14, 2001
11. Falanga V: Growth factors and chronic wounds: the need to understand the microenvironment. J Dermatol 19:667-672, 1992
12. Fields GB, Noble RL: Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int J Pept Protein Res 35:161-214, 1990
13. Frohm M, Gunne H, Bergman AC, et al: Biochemical and antibacterial analysis of human wound and blister fluid. Eur J Biochem 237:86-92, 1996
14. Frohm M, Agerberth B, Ahangari G, Ståhle-Bäckdahl M, Lidén S, Wigzell H, Gudmundsson GH: The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem 272:15258-15263, 1997
15. Frohm Nilsson M, Sandstedt B, Sørensen O, Weber G, Borregaard N, Ståhle-Båckdahl M: The human cationic anti-microbial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect Immun 67:2561-2566, 1999
16. Gallo RL, Ono M, Povsic T, Page C, Eriksson E, Klagsbrun M, Bernfield M: Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich anti-microbial peptide from wounds. Proc Natl Acad Sci USA 91:11035-11039, 1994
17. Ganz T, Lehrer RI: Antibiotic peptides from higher eukaryotes: biology and applications. Mol Med Today 5:292-297, 1999
18. Goldman MJ, Anderson GM, Stolzenberg ED, Kari UP, Zasloff M, Wilson JM: Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88:553-560, 1997
19. Gudmundsson GH, Agerberth B, Odeberg J, Bergman T, Olsson B, Salcedo R: The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur J Biochem 238:325-332, 1996
20. Harder J, Barrels J, Christophers E, Schröder JM: A peptide antibiotic from human skin [letter] [see comments]. Nature 387:861, 1997
21. Herrick SE, Sloan P, McGurk M, Freak L, McCollum CN, Ferguson MW: Sequential changes in histologic pattern and extracellular matrix deposition during the healing of chronic venous ulcers. Am J Pathol 141:1085-1095, 1992
22. Huttner KM, Bevins CL: Antimicrobial peptides as mediators of epithelial host defense. Pediatr Res 45:785-794, 1999
23. Inoue M, Kratz G, Haegerstrand A, Ståhle-Bäckdahl M: Collagenase expression is rapidly induced in wound-edge keratinocytes after acute injury in human skin, persists during healing, and stops at re-epithelialization. J Invest Dermatol 104:479-483, 1995
24. Islam D, Bandholtz L, Nilsson J, Wigzell H, Christensson B, Agerberth B, Gudmundsson G: Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat Med 7:180-185, 2001
25. Johansson J, Gudmundsson GH, Rottenberg ME, Berndt KD, Agerberth B: Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J Biol Chem 273:3718-3724, 1998
26. Kratz G: Modeling of wound healing processes in human skin using tissue culture. Microsc Res Tech 42:345-350, 1998
27. Kratz G, Lake M, Gidlund M: Insulin like growth factor-1 and -2 and their role in the re-epithelialisation of wounds; interactions with insulin like growth factor binding protein type 1. Scand J Plast Reconstr Surg Hand Surg 28:107-112, 1994
28. Larrick JW, Lee J, Ma S, Li X, Francke U, Wright SC, Balint RF: Structural, functional analysis and localization of the human CAP18 gene. FEBS Lett 398:74-80, 1996
29. Lehrer RI, Ganz T: Antimicrobial peptides in mammalian and insect host defence. Curr Opin Immunol 11:23-27, 1999
30. Lehrer RI, Lichtenstein AK, Ganz T: Defensins, antimicrobial and cytotoxic peptides of mammalian cells. Annu Rev Immunol 11:105-128, 1993
31. Li J, Post M, Volk R, et al: PR39, a peptide regulator of angiogenesis [published erratum appears in Nat Med 6(3):356, 2000]. Nat Med 6:49-55, 2000
32. Malm J, Sørensen O, Persson T, et al: The human cationic anti-microbial protein (hCAP-18) is expressed in the epithelium of human epididymis, is present in seminal plasma at high concentrations, and is attached to spermatozoa. Infect Immun 68:4297-4302, 2000
33. Nagaoka I, Hirota S, Niyonsaba F, Hirata M, Adachi Y, Tamura H, Heumann D: Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells. J Immunol 167:3329-3338, 2001
34. Nizet V, Ohtake T, Lauth X, et al: Innate anti-microbial peptide protects the skin from invasive bacterial infection. Nature 414:454-457, 2001
35. Phillips TJ, Palko MJ, Bhawan J: Histologic evaluation of chronic human wounds treated with hydrocolloid and nonhydrocolloid dressings. J Am Acad Dermatol 30:61-64, 1994
36. Phillips TJ, Al-Amoudi HO, Leverkus M, Park HY: Effect of chronic wound fluid on fibroblasts. J Wound Care 7:527-532, 1998
37. Ritonja A, Kopitar M, Jerala R, Turk V: Primary structure of a new cysteine proteinase inhibitor from pig leucocytes. FEBS Lett 255:211-214, 1989
38. Schmidtchen A, Frick I, Björck L: Dermatan sulphate is released by proteinases of common pathogenic bacteria and inactivates antibacterial alpha-defensin. Mol Microbiol 39:708-713, 2001
39. Selsted ME, Brown DM, DeLange RJ, Lehrer RI: Primary structures of MCP-1 and MCP-2, natural peptide antibiotics of rabbit lung macrophages. J Biol Chem 258:14485-14489, 1983
40. Sørensen O, Arnljots K, Cowland JB, Bainton DF, Borregaard N: The human anti-bacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. Blood 90:2796-2803, 1997a
41. Sørensen O, Cowland JB, Askaa J, Borregaard N: An ELISA for hCAP-18, the cathelicidin present in human neutrophils and plasma. J Immunol Methods 206:53-59, 1997b
42. Sørensen OE, Follin P, Johnsen AH, Calafat J, Tjabringa GS, Hiemstra PS, Borregaard N: Human cathelicidin, hCAP-18, is processed to the anti-microbial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 97:3951-3959, 2001
43. Ståhle-Bäckdahl M, Sudbeck BD, Eisen AZ, Welgus HG, Parks WC: Expression of 92-kDa type IV collagenase mRNA by eosinophils associated with basal cell carcinoma. J Invest Dermatol 99:497-503, 1992
44. Trengove NJ, Stacey MC, MacAuley S, et al: Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen 7:442-452, 1999